Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
1. Moderna's flu vaccine showed stronger immune response in late-stage trial. 2. Plans to resubmit applications for standalone and combination flu-Covid vaccines. 3. Efficacy results show 26.6% improvement over standard flu vaccines. 4. Seasonal flu hospitalizations reached a 15-year high, underscoring vaccine need. 5. Moderna's stock is down 30% this year amid regulatory uncertainties.